Krka Enjoys ‘Strongest’ Half Year, Although Prescription Stagnates

Slovenian Firm Publishes Preliminary Results

Detailed map of Slovenia
Only 5% of Krka's sales came from Slovenia • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business